Solving costly tablet manufacturing issues
I Holland to share their 70 years' experience in an ‘ultimate’ tooling seminar.
With more than 70 years of experience in the tablet tooling industry, I Holland has a wealth of knowledge on productive manufacturing techniques. In order to share their expertise, the company will be hosting the ‘Ultimate Guide to Compression Tooling’ seminar on 19-20 September at its head office in Nottingham, UK.
I Holland’s leading team of experts have created a seminar which looks at all the major factors in compression tooling, including common problems encountered during tablet production, punch and die design, tooling specification and how by improving maintenance and aftercare procedures downtime can be significantly reduced.
Marianna D’Onghia, I Holland’s host for the event said: “The Ultimate Guide to Compression Tooling seminar really is an all-encompassing view at tablet tooling. It has run on several occasions and has proved to be extremely popular with customers joining us from around the world.
“The team of experts at I Holland have an enormous pool of experience in various areas of tablet tooling, from design to maintenance. Combining this with over 70 years of research and development, I Holland can really help companies with their tablet manufacturing processes.
“In light of the increased pressure on manufacturers to get a quality product out quickly and cost-effectively, we are called on more frequently to solve tablet manufacturing problems. The seminar has been designed specifically for production managers, press operators and those directly involved in tooling maintenance and will include sharing information on industry trends and tooling expertise to help avoid costly production issues in both money and time. All of the information shared will help in effectively producing quality tablets and relieving customer pressure.
“The seminar will include focusing on some of the most common problems encountered during production including sticking, picking, corrosion, abrasion and tooling damage. There will also be a tour of I Holland’s facilities, where delegates can see punch manufacture from design through to despatch of the final product. It will also give us the opportunity to discuss individual cases with those that attend both in group and individual scenarios. We can then gain informative feedback on how I Holland can further assist in problem-solving.”
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.